Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Negative Surgical Margins”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01080521
What this trial is testing

Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy

Who this might be right for
Cognitive Side Effects of Cancer TherapyMalignant Ovarian Epithelial TumorOvarian Brenner Tumor+51 more
Gynecologic Oncology Group 247
Not applicableStudy completedNCT05394324
What this trial is testing

A Post-market Clinical Study to Collect Safety and Performance Data on Johnson & Johnson Surgical Vision Products

Who this might be right for
Refractive ErrorGlaucomaCataracts+1 more
Johnson & Johnson Surgical Vision, Inc. 1,674
Large-scale testing (Phase 3)Looking for participantsNCT07197580
What this trial is testing

Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC

Who this might be right for
ccRCCRenal Cell Carcinoma (Kidney Cancer)Renal Cell Carcinoma (RCC)+3 more
Telix Pharmaceuticals (Innovations) Pty Limited 40
Not applicableLooking for participantsNCT07251803
What this trial is testing

GLP1 Fasting Status and Gastric Retention Using Gastric Ultrasound

Who this might be right for
Gastric Retention
Medical University of South Carolina 150
Early research (Phase 1)Active Not RecruitingNCT02142803
What this trial is testing

TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors

Who this might be right for
Adult GlioblastomaEndometrial Clear Cell AdenocarcinomaEndometrial Serous Adenocarcinoma+21 more
National Cancer Institute (NCI) 50
Early research (Phase 1)Study completedNCT04148937
What this trial is testing

The CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer

Who this might be right for
Advanced Cancer
Eli Lilly and Company 52
Not applicableNot Yet RecruitingNCT06561945
What this trial is testing

Accuracy of Dental Movements Using Clear Aligners Treatment: a Single-center Prospective Observational Study

Who this might be right for
Malocclusion
IRCCS Ospedale San Raffaele 100
Testing effectiveness (Phase 2)Study completedNCT00003657
What this trial is testing

High-dose ICE With Amifostine

Who this might be right for
Bladder CancerBrain and Central Nervous System TumorsCarcinoma of Unknown Primary+8 more
Dana-Farber Cancer Institute 24
Not applicableStudy completedNCT06814262
What this trial is testing

Effect of Clear Aligner Attachment Size on Extrusion of Maxillary Lateral Incisors

Who this might be right for
Orthodontic Appliance Complication
Virginia Commonwealth University 28
Testing effectiveness (Phase 2)Study completedNCT00928642
What this trial is testing

Gleevec and Gemzar in Patients With Epithelial Ovarian Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cancer
Henry M. Jackson Foundation for the Advancement of Military Medicine 8
Testing effectiveness (Phase 2)Looking for participantsNCT06617923
What this trial is testing

Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer

Who this might be right for
Ovary CancerFallopian Tube CancerPrimary Peritoneal Cavity Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 18
Not applicableStudy completedNCT04866238
What this trial is testing

Comparison of Oral Health Related Quality of Life Changes Between Clear Aligners and Vestibular Fixed Appliances

Who this might be right for
Teeth Crowding
Damascus University 36
Large-scale testing (Phase 3)Study completedNCT01120249
What this trial is testing

S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery

Who this might be right for
Kidney Cancer
SWOG Cancer Research Network 1,545
Testing effectiveness (Phase 2)Looking for participantsNCT05267626
What this trial is testing

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Who this might be right for
Advanced Solid TumorMetastatic CancerCutaneous Melanoma+1 more
Aulos Bioscience, Inc. 159
Testing effectiveness (Phase 2)Looking for participantsNCT05263050
What this trial is testing

Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors

Who this might be right for
Metastatic Renal Cell CarcinomaClear-cell Metastatic Renal Cell CarcinomaNeuroendocrine Tumors+1 more
Fox Chase Cancer Center 111
Testing effectiveness (Phase 2)Study completedNCT00073515
What this trial is testing

Trial of a Novel Fibrinolytic (Alfimeprase) to Clear Thrombosed Vascular Access Devices

Who this might be right for
Catheters, Indwelling
ARCA Biopharma, Inc. 115
Not applicableStudy completedNCT07415876
What this trial is testing

Evaluating Urinary CXCL10 for Enhanced Detection of Acute Rejection in Kidney Transplant Patients With Low DD-CFDNA

Who this might be right for
Kidney Transplant Rejection
Virginia Commonwealth University 20
Post-approval studies (Phase 4)WithdrawnNCT00856089
What this trial is testing

Efficacy Study of Altabax to Clear Methicillin-resistant Staphylococcus Aureus (MRSA) Nasal Colonization

Who this might be right for
Methicillin-resistant Staphylococcus Aureus
Ochsner Health System
Testing effectiveness (Phase 2)Study completedNCT01896271
What this trial is testing

High Dose IL-2 and Stereotactic Ablative Body Radiation Therapy for Metastatic Renal Cancer

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
University of Texas Southwestern Medical Center 30
Early research (Phase 1)Looking for participantsNCT07072234
What this trial is testing

Phase I Study of Allogeneic Transforming Growth Factor-beta Receptor Type 2 Knockout CD70 CAR NK Cells in Treatment Refractory Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell CarcinomaPhase 1Growth Factor
M.D. Anderson Cancer Center 30
Next Page